Clinical Trials

NCT05946213 | RECRUITING | PHASE3

1209 Participants

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-12-14

Completion: 2036-03-31

Conditions

Prostate Adenocarcinoma Stage III Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8

Interventions

PROCEDURE RADIATION OTHER

No Results Yet

NCT05937776 | RECRUITING

20 Participants

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Study Type: OBSERVATIONAL

Last Updated: 2025-11-10

Start Date: 2023-12-11

Completion: 2025-12-31

Conditions

Glioma

Interventions

OTHER PROCEDURE

No Results Yet

NCT05929937 | RECRUITING | PHASE4

904 Participants

No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-07-10

Completion: 2027-06-30

Conditions

Postoperative Pain Inguinal Hernia

Interventions

DRUG OTHER

No Results Yet

NCT05927532 | COMPLETED | NA

40 Participants

Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-03-10

Completion: 2024-12-15

Conditions

End Stage Renal Failure on Dialysis

Interventions

DEVICE

No Results Yet

NCT05923073 | RECRUITING | PHASE3

120 Participants

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-03-13

Completion: 2027-10-27

Conditions

Crohn's Disease

Interventions

DRUG

No Results Yet

NCT05913908 | RECRUITING | NA

15 Participants

EFS of the DUO System for Tricuspid Regurgitation

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-08-13

Completion: 2025-12-31

Conditions

Tricuspid Regurgitation Tricuspid Valve Insufficiency Tricuspid Valve Disease Heart Valve Diseases

Interventions

DEVICE

No Results Yet

NCT05912517 | RECRUITING | PHASE3

120 Participants

A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-12-20

Completion: 2027-08-05

Conditions

Hemolytic Disease of the Fetus and Newborn

Interventions

DRUG

No Results Yet

NCT05911997 | RECRUITING | PHASE1

60 Participants

MTC Versus FMT in for RCDI

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-01-08

Completion: 2026-07-25

Conditions

Clostridiodies Difficile Infections

Interventions

DRUG

No Results Yet

NCT05908734 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

71 Participants

A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-05-18

Completion: 2026-01-30

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

No Results Yet

NCT05904080 | RECRUITING | PHASE2

50 Participants

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-02-19

Completion: 2028-06-16

Conditions

Metastatic Nasopharyngeal Carcinoma Recurrent Nasopharyngeal Carcinoma Stage IV Nasopharyngeal Carcinoma AJCC v8

Interventions

PROCEDURE DRUG BIOLOGICAL

No Results Yet

NCT05902169 | ACTIVE_NOT_RECRUITING | PHASE3

560 Participants

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-01-29

Completion: 2028-01-28

Conditions

Glioblastoma Recurrent Glioblastoma GBM

Interventions

DEVICE DRUG

No Results Yet

NCT05899049 | ACTIVE_NOT_RECRUITING | PHASE3

249 Participants

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2022-07-27

Completion: 2027-06-07

Conditions

Carcinoma, Renal Cell

Interventions

BIOLOGICAL DRUG

No Results Yet

NCT05898620 | RECRUITING | PHASE3

33 Participants

A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-06-13

Completion: 2029-12-31

Conditions

Rett Syndrome

Interventions

GENETIC

No Results Yet

NCT05896839 | RECRUITING | PHASE1/PHASE2

16 Participants

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-07-24

Completion: 2027-01-31

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 Metastatic Basal Cell Carcinoma Metastatic Carcinoma in the Skin Metastatic Melanoma Metastatic Merkel Cell Carcinoma Metastatic Skin Squamous Cell Carcinoma Unresectable Basal Cell Carcinoma Unresectable Melanoma Unresectable Merkel Cell Carcinoma Unresectable Skin Squamous Cell Carcinoma

Interventions

PROCEDURE BIOLOGICAL DRUG

No Results Yet

NCT05893797 | COMPLETED | NA

36 Participants

A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-10-05

Completion: 2024-09-16

Conditions

Type 1 Diabetes Type 2 Diabetes Type 2 Diabetes Treated With Insulin

Interventions

DRUG DEVICE

Results Available

NCT05884398 | ACTIVE_NOT_RECRUITING | PHASE3

420 Participants

A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-08-31

Completion: 2026-10-12

Conditions

Metastatic Castrate-sensitive Prostate Cancer

Interventions

DRUG

No Results Yet

NCT05877300 | RECRUITING | PHASE1

10 Participants

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-07-13

Completion: 2026-07-31

Conditions

Esophageal Diseases

Interventions

COMBINATION_PRODUCT

No Results Yet

NCT05876923 | RECRUITING | NA

70 Participants

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-06-12

Completion: 2028-03-13

Conditions

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Indolent Non-hodgkin Lymphoma

Interventions

PROCEDURE OTHER

No Results Yet

NCT05868330 | RECRUITING | PHASE4

56 Participants

Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-08-19

Completion: 2026-10-31

Conditions

Post Operative Pain Anesthesia Nerve Block Shoulder Osteoarthritis

Interventions

PROCEDURE

No Results Yet

NCT05860413 | COMPLETED | NA

57 Participants

Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-01-24

Completion: 2025-05-20

Conditions

Type 2 Diabetes

Interventions

BEHAVIORAL

No Results Yet

NCT05848089 | COMPLETED | NA

41 Participants

Real-time Intervention for Suicide Risk Reduction

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-09-25

Completion: 2024-09-16

Conditions

Suicidal Ideation Suicide Attempt

Interventions

BEHAVIORAL

No Results Yet

NCT05843643 | RECRUITING | PHASE3

1000 Participants

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-07-19

Completion: 2026-12-31

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

No Results Yet

NCT05843253 | RECRUITING | PHASE2

120 Participants

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-08-22

Completion: 2029-08-31

Conditions

High Grade Glioma Diffuse Intrinsic Pontine Glioma Anaplastic Astrocytoma Glioblastoma Glioblastoma Multiforme Diffuse Midline Glioma, H3 K27M-Mutant Metastatic Brain Tumor WHO Grade III Glioma WHO Grade IV Glioma Diffuse Hemispheric Glioma, H3 G34-Mutant

Interventions

DRUG

No Results Yet

NCT05841030 | ACTIVE_NOT_RECRUITING

544 Participants

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

Study Type: OBSERVATIONAL

Last Updated: 2025-11-10

Start Date: 2023-04-28

Completion: 2025-11-21

Conditions

Depressive Disorder, Major

Interventions

OTHER

No Results Yet

NCT05840159 | RECRUITING | PHASE4

664 Participants

A Study of Doxycycline to Treat Chlamydial Infection

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2024-01-19

Completion: 2026-02-28

Conditions

Chlamydial Infection

Interventions

DRUG OTHER

No Results Yet

NCT05839379 | RECRUITING

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2023-06-20

Completion: 2032-01-29

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

No Results Yet